14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AZN.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AstraZeneca PLC stock upgraded to Strong Buy Candidate.
(Updated on Apr 24, 2024)

Buy candidate since Apr 10, 2024 Gain 5.78% PDF

The AstraZeneca PLC stock price gained 0.745% on the last trading day (Wednesday, 24th Apr 2024), rising from £11,268.00 to £11,352.00. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.10% from a day low at £11,288.00 to a day high of £11,412.00. The price has risen in 7 of the last 10 days and is up by 5.78% over the past 2 weeks. Volume fell on the last day by -981 thousand shares and in total, 2 million shares were bought and sold for approximately £25.19 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at £11,426.38 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 8.38% during the next 3 months and, with a 90% probability hold a price between £11,068.65 and £12,383.47 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AZN.L Signals & Forecast

Mostly positive signals in the chart today. The AstraZeneca PLC stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at £11,067.14 and £10,618.29. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, February 12, 2024, and so far it has risen 19.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for AstraZeneca PLC stock

On the downside, the stock finds support just below today's level from accumulated volume at £10,450.00 and £10,036.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AstraZeneca PLC finds support just below today's level at £10,450.00. If this is broken, then the next support from accumulated volume will be at £10,036.00 and £9,724.00.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved £124.00 (1.10%) between high and low. For the last week, the stock has had daily average volatility of 1.67%.

Our recommended stop-loss: £11,009.17 (-3.02%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 50 days ago.)

Trading Expectations (AZN.L) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect AstraZeneca PLC to open at £11,350.67, and during the day (based on 14 day Average True Range), to move between £11,165.09 and £11,538.91, which gives a possible trading interval of +/-£186.91 (+/-1.65%) up or down from last closing price. If AstraZeneca PLC takes out the full calculated possible swing range there will be an estimated 3.29% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ £10,450.00, some £902.00 (7.95%) from the current price of £11,352.00, our system finds the risk reward attractive.

Earnings coming up

AstraZeneca PLC will release earnings BMO on Thursday, April 25, 2024.The consensus among the analysts for the expected earnings (EPS) is $1.54. We will update the financials statements for AstraZeneca PLC, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.40% in the first trading day after earnings release.

Is AstraZeneca PLC stock A Buy?

AstraZeneca PLC holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.782 Strong Buy Candidate Upgraded

Predicted Opening Price for AstraZeneca PLC of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
£11,350.67 ( 0.0117%) £11,352.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AZN.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11,474.67 1.08 %
R2 11,427.30 0.663 %
R1 11,398.03 0.406 %
Current price: 11,352.00
Support S1 11,303.30 -0.429 %
S2 11,274.03 -0.687 %
S3 11,226.67 -1.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 11,352.00
Support S1 10,450.00 -7.95%
S2 10,036.00 -11.59%
S3 9,724.00 -14.34%

AZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 22, 2024 Feb 22, 2024 Mar 25, 2024 £156.00 1.50%
2 Feb 09, 2023 Feb 23, 2023 Mar 27, 2023 £162.80 1.45%
3 Jul 29, 2022 Aug 11, 2022 Sep 12, 2022 £76.40 0.719%
4 Feb 10, 2022 Feb 24, 2022 Mar 28, 2022 £145.30 1.47%
5 Jul 29, 2021 Aug 12, 2021 Sep 13, 2021 £64.80 0.80%

FAQ

What is the symbol for AstraZeneca PLC Stock and on which exchange is it traded?
The symbol for AstraZeneca PLC is AZN.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell AstraZeneca PLC Stock?
AstraZeneca PLC holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy AstraZeneca PLC Stock?
AstraZeneca PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AstraZeneca PLC Stock.

What's the current price of AstraZeneca PLC Stock?
As of the end of day on the Apr 24, 2024, the price of an AstraZeneca PLC (AZN.L) share was £11,352.00.

What is the 52-week high and low for AstraZeneca PLC Stock?
The 52-week high for AstraZeneca PLC Stock is £12,348.00 and the 52-week low is £9,463.00.

What is the market capitalization of AstraZeneca PLC Stock?
As of the Apr 24, 2024, the market capitalization of AstraZeneca PLC is 175.486B.

When is the next earnings date for AstraZeneca PLC?
The upcoming earnings date for AstraZeneca PLC is Apr 25, 2024.
Click to get the best stock tips daily for free!

About AstraZeneca PLC

AstraZeneca PLC AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/... AZN.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT